SOPH

insider transactions

SOPHiA GENETICS SA — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 30d

-2.5K

20.0K buy · 22.5K sell

Net value · 30d

-$15.1K

$99.0K in · $114.1K out

Sentiment · 30d

Net selling

46% buying · 54% selling

Open-market trades · 30d

20.0K buy · 22.5K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

Transactions · 30d

Open-market Buys Sells All types

Grant·A
Jun 18, 26

Ossipow Vincent

Director

$157.3K

28.8K sh · $5.46

Own +26%
Grant·A
Jun 18, 26

Ossipow Vincent

Director

$107.7K

19.7K sh · $5.46

Own +4%
Grant·A
Jun 18, 26

HIRSCH DIDIER

Director

$157.3K

28.8K sh · $5.46

Own +15%
Grant·A
Jun 18, 26

HIRSCH DIDIER

Director

$107.7K

19.7K sh · $5.46

Own +9%
Grant·A
Jun 18, 26

HIBBS KATHY L

Director

$157.3K

28.8K sh · $5.46

Own +15%
Grant·A
Jun 18, 26

HIBBS KATHY L

Director

$107.7K

19.7K sh · $5.46

Own +22%
Grant·A
Jun 18, 26

Cox Troy

Director

$157.3K

28.8K sh · $5.46

Own +13%
Grant·A
Jun 18, 26

Cox Troy

Director

$107.7K

19.7K sh · $5.46

Own +6%
Grant·A
Jun 18, 26

Jean-Michel Cossery

Director

$157.3K

28.8K sh · $5.46

Own +26%
Grant·A
Jun 18, 26

Jean-Michel Cossery

Director

$107.7K

19.7K sh · $5.46

Own +11%
Sell·S
Jun 15, 26

Xu Zhenyu

Chief Scientific Officer · 10b5-1

$20.1K

4.0K sh · $5.01

Own -1%
Sell·S
Jun 12, 26

Menu Philippe

Chief Medical Officer · 10b5-1

$24.8K

5.0K sh · $4.95

Own -2%
Sell·S
Jun 10, 26

Camblong Jurgi KEY

Chief Executive Officer · 10b5-1

$44.5K

8.5K sh · $5.24

Own -0%
Buy·P
Jun 5, 26

CARDOZA GEORGE KEY

Chief Financial Officer

$99.0K

20.0K sh · $4.95

Own +7%
Sell·S
May 26, 26

Menu Philippe

Chief Medical Officer · 10b5-1

$24.8K

5.0K sh · $4.95

Own -2%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 18, 2026	Ossipow Vincent	Director	Grant A	28.8K	+26%	$5.46	$157.3K
Jun 18, 2026	Ossipow Vincent	Director	Grant A	19.7K	+4%	$5.46	$107.7K
Jun 18, 2026	HIRSCH DIDIER	Director	Grant A	28.8K	+15%	$5.46	$157.3K
Jun 18, 2026	HIRSCH DIDIER	Director	Grant A	19.7K	+9%	$5.46	$107.7K
Jun 18, 2026	HIBBS KATHY L	Director	Grant A	28.8K	+15%	$5.46	$157.3K
Jun 18, 2026	HIBBS KATHY L	Director	Grant A	19.7K	+22%	$5.46	$107.7K
Jun 18, 2026	Cox Troy	Director	Grant A	28.8K	+13%	$5.46	$157.3K
Jun 18, 2026	Cox Troy	Director	Grant A	19.7K	+6%	$5.46	$107.7K
Jun 18, 2026	Jean-Michel Cossery	Director	Grant A	28.8K	+26%	$5.46	$157.3K
Jun 18, 2026	Jean-Michel Cossery	Director	Grant A	19.7K	+11%	$5.46	$107.7K
Jun 15, 2026	Xu Zhenyu 10b5-1	Chief Scientific Officer	Sell S	4.0K	-1%	$5.01	$20.1K
Jun 12, 2026	Menu Philippe 10b5-1	Chief Medical Officer	Sell S	5.0K	-2%	$4.95	$24.8K
Jun 10, 2026	Camblong Jurgi KEY 10b5-1	Chief Executive Officer	Sell S	8.5K	-0%	$5.24	$44.5K
Jun 5, 2026	CARDOZA GEORGE KEY	Chief Financial Officer	Buy P	20.0K	+7%	$4.95	$99.0K
May 26, 2026	Menu Philippe 10b5-1	Chief Medical Officer	Sell S	5.0K	-2%	$4.95	$24.8K

Buy Sell Non-market (grant · exercise · gift)

About SOPH insider trading

This page tracks insider transactions for SOPHiA GENETICS SA (SOPH) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.